Literature DB >> 22652185

The role of saposin C in Gaucher disease.

Rafael J Tamargo1, Arash Velayati, Ehud Goldin, Ellen Sidransky.   

Abstract

Saposin C is one of four homologous proteins derived from sequential cleavage of the saposin precursor protein, prosaposin. It is an essential activator for glucocerebrosidase, the enzyme deficient in Gaucher disease. Gaucher disease is a rare autosomal recessive lysosomal storage disorder caused by mutations in the GBA gene that exhibits vast phenotypic heterogeneity, despite its designation as a "simple" Mendelian disorder. The observed phenotypic variability has led to a search for disease modifiers that can alter the Gaucher phenotype. The PSAP gene encoding saposin C is a prime candidate modifier for Gaucher disease. In humans, saposin C deficiency due to mutations in PSAP results in a Gaucher-like phenotype, despite normal in vitro glucocerebrosidase activity. Saposin C deficiency has also been shown to modify phenotype in one mouse model of Gaucher disease. The role of saposin C as an activator required for normal glucocerebrosidase function, and the consequences of saposin C deficiency are described, and are being explored as potential modifying factors in patients with Gaucher disease. Published by Elsevier Inc.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22652185      PMCID: PMC3534739          DOI: 10.1016/j.ymgme.2012.04.024

Source DB:  PubMed          Journal:  Mol Genet Metab        ISSN: 1096-7192            Impact factor:   4.797


  94 in total

1.  The iminosugar isofagomine increases the activity of N370S mutant acid beta-glucosidase in Gaucher fibroblasts by several mechanisms.

Authors:  Richard A Steet; Stephen Chung; Brandon Wustman; Allan Powe; Hung Do; Stuart A Kornfeld
Journal:  Proc Natl Acad Sci U S A       Date:  2006-08-31       Impact factor: 11.205

2.  Analyses of variant acid beta-glucosidases: effects of Gaucher disease mutations.

Authors:  Benjamin Liou; Andrzej Kazimierczuk; Min Zhang; C Ronald Scott; Rashmi S Hegde; Gregory A Grabowski
Journal:  J Biol Chem       Date:  2005-11-17       Impact factor: 5.157

Review 3.  Molecular chaperones in protein folding and proteostasis.

Authors:  F Ulrich Hartl; Andreas Bracher; Manajit Hayer-Hartl
Journal:  Nature       Date:  2011-07-20       Impact factor: 49.962

Review 4.  The immunological functions of saposins.

Authors:  Alexandre Darmoise; Patrick Maschmeyer; Florian Winau
Journal:  Adv Immunol       Date:  2010       Impact factor: 3.543

5.  The lysosomal trafficking of sphingolipid activator proteins (SAPs) is mediated by sortilin.

Authors:  Stephane Lefrancois; Jibin Zeng; A Jacob Hassan; Maryssa Canuel; Carlos R Morales
Journal:  EMBO J       Date:  2003-12-15       Impact factor: 11.598

6.  Lysosomal degradation on vesicular membrane surfaces. Enhanced glucosylceramide degradation by lysosomal anionic lipids and activators.

Authors:  G Wilkening; T Linke; K Sandhoff
Journal:  J Biol Chem       Date:  1998-11-13       Impact factor: 5.157

7.  In situ radiation-inactivation size of fibroblast membrane-bound acid beta-glucosidase in Gaucher type 1, type 2 and type 3 disease.

Authors:  F Y Choy; M Woo; M Potier
Journal:  Biochim Biophys Acta       Date:  1986-03-07

8.  Identification of prosaposin as a neurotrophic factor.

Authors:  J S O'Brien; G S Carson; H C Seo; M Hiraiwa; Y Kishimoto
Journal:  Proc Natl Acad Sci U S A       Date:  1994-09-27       Impact factor: 11.205

9.  Non-neuronopathic Gaucher disease due to saposin C deficiency.

Authors:  A Tylki-Szymańska; B Czartoryska; M-T Vanier; B J M H Poorthuis; J A E Groener; A Ługowska; G Millat; A M Vaccaro; E Jurkiewicz
Journal:  Clin Genet       Date:  2007-10-07       Impact factor: 4.438

Review 10.  Gaucher disease: mutation and polymorphism spectrum in the glucocerebrosidase gene (GBA).

Authors:  Kathleen S Hruska; Mary E LaMarca; C Ronald Scott; Ellen Sidransky
Journal:  Hum Mutat       Date:  2008-05       Impact factor: 4.878

View more
  39 in total

1.  Quantitative Proteomics of Human Fibroblasts with I1061T Mutation in Niemann-Pick C1 (NPC1) Protein Provides Insights into the Disease Pathogenesis.

Authors:  Navin Rauniyar; Kanagaraj Subramanian; Mathieu Lavallée-Adam; Salvador Martínez-Bartolomé; William E Balch; John R Yates
Journal:  Mol Cell Proteomics       Date:  2015-04-14       Impact factor: 5.911

2.  Mechanism of glucocerebrosidase activation and dysfunction in Gaucher disease unraveled by molecular dynamics and deep learning.

Authors:  Raquel Romero; Arvind Ramanathan; Tony Yuen; Debsindhu Bhowmik; Mehr Mathew; Lubna Bashir Munshi; Seher Javaid; Madison Bloch; Daria Lizneva; Alina Rahimova; Ayesha Khan; Charit Taneja; Se-Min Kim; Li Sun; Maria I New; Shozeb Haider; Mone Zaidi
Journal:  Proc Natl Acad Sci U S A       Date:  2019-02-26       Impact factor: 11.205

Review 3.  Exploring genetic modifiers of Gaucher disease: The next horizon.

Authors:  Brad A Davidson; Shahzeb Hassan; Eric Joshua Garcia; Nahid Tayebi; Ellen Sidransky
Journal:  Hum Mutat       Date:  2018-09-11       Impact factor: 4.878

Review 4.  The protective role of prosaposin and its receptors in the nervous system.

Authors:  Rebecca C Meyer; Michelle M Giddens; Brilee M Coleman; Randy A Hall
Journal:  Brain Res       Date:  2014-08-15       Impact factor: 3.252

5.  Identification of miRNAs that modulate glucocerebrosidase activity in Gaucher disease cells.

Authors:  Marina Siebert; Wendy Westbroek; Yu-Chi Chen; Nima Moaven; Yan Li; Arash Velayati; Maria Luiza Saraiva-Pereira; Scott E Martin; Ellen Sidransky
Journal:  RNA Biol       Date:  2014       Impact factor: 4.652

6.  Progranulin mutations result in impaired processing of prosaposin and reduced glucocerebrosidase activity.

Authors:  Clarissa Valdez; Daniel Ysselstein; Tiffany J Young; Jianbin Zheng; Dimitri Krainc
Journal:  Hum Mol Genet       Date:  2020-03-27       Impact factor: 6.150

Review 7.  Defective Lysosomal Lipid Catabolism as a Common Pathogenic Mechanism for Dementia.

Authors:  Jun Yup Lee; Oana C Marian; Anthony S Don
Journal:  Neuromolecular Med       Date:  2021-02-07       Impact factor: 3.843

8.  Saposin C protects glucocerebrosidase against α-synuclein inhibition.

Authors:  Thai Leong Yap; James M Gruschus; Arash Velayati; Ellen Sidransky; Jennifer C Lee
Journal:  Biochemistry       Date:  2013-10-01       Impact factor: 3.162

9.  Sequencing of the GBA coactivator, Saposin C, in Parkinson disease.

Authors:  Bouchra Ouled Amar Bencheikh; Etienne Leveille; Jennifer A Ruskey; Dan Spiegelman; Christopher Liong; Edward A Fon; Guy A Rouleau; Yves Dauvilliers; Nicolas Dupre; Roy N Alcalay; Ziv Gan-Or
Journal:  Neurobiol Aging       Date:  2018-07-02       Impact factor: 4.673

Review 10.  Dysregulation of the autophagic-lysosomal pathway in Gaucher and Parkinson's disease.

Authors:  Caleb Pitcairn; Willayat Yousuf Wani; Joseph R Mazzulli
Journal:  Neurobiol Dis       Date:  2018-03-14       Impact factor: 5.996

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.